Skip to main content
Hit enter to search or ESC to close
Study of safety and effectiveness of topical administration (eye drops) of sitagliptin for treating early stages of diabetic retinopathy (EyeSit@)
© 2024 VHIR Annual Report 2022.
Data protection policy
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2022